Dan Latham
Biography
Overview
Dan represents many of the Firm's largest corporate and private equity sponsors. He focuses on complex, cross-border mergers and acquisitions, and has worked on some of the Firm's largest and most complex M&A transactions. He has significant experience in managing large, multijurisdictional transactions that often involve multiple White & Case offices across numerous time zones, including representing many of the Firm's Chinese clients in their strategic US inbound acquisitions. Dan's industry experience includes energy, oil & gas, retail, aircraft leasing, private equity, medical devices, healthcare and manufacturing.
In addition to his multijurisdictional M&A practice, Dan has also advised on numerous in- and out-of-court debt and equity restructuring transactions. He regularly works with the Firm's Financial Restructuring group on debtor sale transactions and strategic investor transactions.
His practice also includes advising boards of directors on corporate governance matters.
Experience
Noteworthy transactions include the representation of:
Macquarie Infrastructure Corp. (NYSE: MIC) and its related entities in the US$4.475 billion sale of its Atlantic Aviation business to a special purpose entity of Kohlberg Kravis Roberts & Co. L.P.
DIC Corporation, a Japanese fine chemicals company, and its US subsidiary Sun Chemical Corporation, in connection with DIC's €1.15 billion acquisition of BASF's global pigments business, known as BASF Colors & Effects.
Newlight Partners LP in its equity investment into Bioenergy Development Group Holdco, LLC and its subsidiaries, a group of companies based primarily in Delaware, Maryland and Italy developing and implementing anaerobic digestion technologies in the US and overseas.
Seaspan Corporation, the world's largest independent containership owner-operator, in its acquisition of the remaining 89% of Greater China Intermodal Investments LLC it did not previously own from affiliates of The Carlyle Group and other minority owners at an implied enterprise value of US$1.6 billion.
Pilot Travel Centers, LLC and the Haslam family in connection with Berkshire Hathaway's acquisition of a 38.6% interest in Pilot and its acquisition of a controlling stake in 2023.
The Houston Rockets and its owner Mr. Leslie Alexander in connection with the US$2.2 billion sale of the team and rights to the Toyota Center in Houston to Tilman Fertitta.
bolttech Holdings Ltd., an international insurtech company, on its US$180 million series A equity financing round, which values bolttech at more than US$1 billion - giving bolttech unicorn status only one year after its launch in 2020. Activant Capital Group acted as lead investor in the equity financing round.
The CityMD management team in connection with the US$600 million sale of CityMD to Warburg Pincus and CityMD's subsequent acquisition of Summit Medical Group.
Saudi Refining, Inc. (SRI), a wholly owned subsidiary of Saudi Arabian Oil Company (Saudi Aramco), in the discontinuation of Motiva Enterprises LLC and the division of Motiva's assets, liabilities and businesses between SRI and affiliates of its joint venture partner, Royal Dutch Shell PLC.
Qingdao Haier, a company that is 41% owned by the leading Chinese home appliance manufacturer Haier Group Corp., in its US$5.4 billion acquisition of GE's appliance business, through an auction process. The transaction was named "Cross-border M&A Deal of the Year" by The M&A Advisor 2017.
Consolidated Energy, the world's second largest merchant producer of methanol, in connection with its acquisition of a 50% interest in Natgasoline, LLC, an OCI subsidiary, for US$630 million.
Shenzhen Hepalink Pharmaceutical Co., Ltd in its US$337.5 million acquisition of Scientific Protein Laboratories from American Capital, Ltd. and its US$200 million acquisition of Cytovance Biologics from Great Point Partners.
Coinmach in connection with its simultaneous US$300 million acquisition of AIR-serv Group LLC from Macquarie Capital and US$1.1 billion sale of Coinmach and Air-serv to Pamplona Capital Management.
Anthem, Inc. in its US$4.675 billion disposition of its NextRx Inc. pharmacy benefit management business to Express Scripts, Inc.
Nordic Capital in connection with its US$4.1 billion acquisition of the ConvaTec division of Bristol-Myers Squibb.
Royal Ahold in its US$7.1 billion sale of broad-line food distributor US Foodservice to an affiliate of private equity firms Kohlberg, Kravis Roberts & Co. and Clayton, Dubilier & Rice. Dan also represented Royal Ahold in connection with its acquisition of US Foodservice.
Royal Ahold's Giant-Carlisle division in connection with several asset acquisitions including its US$106 million acquisition of 15 supermarkets from Genuardi's Family Markets, a subsidiary of Safeway, and its US$140 million acquisition of 25 supermarkets from the Ukrop family.
Stop & Shop Supermarket Company LLC, a subsidiary of Royal Ahold, as a stalking-bidder in connection with Stop & Shop's US$146.3 million acquisition of 25 supermarkets from Great Atlantic & Pacific Tea Company, Inc. (A&P), pursuant to a sale order under section 363 of the US Bankruptcy Code.
Leading Lawyer for Private Equity in the United States, Euromoney's Expert Guide, 2021
The Best Lawyers in America: Leveraged Buyouts and Private Equity Law, 2021
M&A/Private Equity/Mega-Deals, The Legal 500 USA, 2009
